Focus, also termed sustained attention or concentration, refers to the cognitive capacity to maintain task engagement while filtering distractors over time. It depends on prefrontal-striatal networks modulated by dopamine and norepinephrine, and is degraded by sleep deprivation, chronic stress, nutritional deficiency, and cognitive overload. Subclinical focus complaints in adults without diagnosed ADHD are common and often improve with foundational interventions (sleep regulation, exercise, workload management) before supplementation is warranted.
Supplementation evidence for attention in non-ADHD populations shows modest but measurable effects. The L-theanine plus caffeine combination (200mg L-theanine plus 100mg caffeine) has the strongest acute-effect evidence, with effect sizes SMD 0.3-0.5 in attention tasks. L-theanine appears to blunt caffeine’s anxiogenic effects while preserving alertness benefits. Rhodiola rosea (200-400mg standardized to 3% rosavins, 1% salidroside) shows effect in fatigue-related attention with SMD approximately 0.4 in 8-week RCTs. Bacopa monnieri (300mg standardized extract) improves memory and attention but requires 8-12 weeks of continuous dosing before effects manifest.
For individuals with clinically diagnosed ADHD, supplement interventions function as adjuncts to first-line pharmacotherapy (stimulants), not replacements; see the ADHD Supplement Stack protocol. For subclinical attention complaints, screen for modifiable contributors (sleep disorders, thyroid dysfunction, iron/B12/D deficiency, depression, anxiety) before pursuing nootropic interventions, since addressing these produces larger and more durable effects than any supplement.